Celularity (CELU) Capital Expenditures (2020 - 2024)
Celularity (CELU) has disclosed Capital Expenditures for 5 consecutive years, with $91000.0 as the latest value for Q4 2024.
- For Q4 2024, Capital Expenditures fell 69.26% year-over-year to $91000.0; the TTM value through Dec 2024 reached $161000.0, down 84.64%, while the annual FY2024 figure was $161000.0, 84.64% down from the prior year.
- Capital Expenditures hit $91000.0 in Q4 2024 for Celularity, up from $59000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $22.7 million in Q4 2020 and bottomed at -$3.8 million in Q4 2022.
- Average Capital Expenditures over 5 years is $1.9 million, with a median of $291500.0 recorded in 2021.
- On a YoY basis, Capital Expenditures climbed as much as 253.66% in 2022 and fell as far as 182.01% in 2022.
- Celularity's Capital Expenditures stood at $22.7 million in 2020, then tumbled by 79.71% to $4.6 million in 2021, then crashed by 182.01% to -$3.8 million in 2022, then soared by 107.84% to $296000.0 in 2023, then crashed by 69.26% to $91000.0 in 2024.
- According to Business Quant data, Capital Expenditures over the past three periods came in at $91000.0, $59000.0, and $11000.0 for Q4 2024, Q2 2024, and Q1 2024 respectively.